Olivet Nazarene University

Digital Commons @ Olivet
Faculty Scholarship – Chemistry

Chemistry

10-13-2015

Anti-TB and Antibacterial Activities of Natural
Products Extracts
Douglas Armstrong
Olivet Nazarene University, darmstrg@olivet.edu

Nathan Krause
Olivet Nazarene University

Drew Frey
Olivet Nazarene University

Follow this and additional works at: https://digitalcommons.olivet.edu/chem_facp
Part of the Bacteria Commons, Biochemistry Commons, Biomedical and Dental Materials
Commons, Medicinal-Pharmaceutical Chemistry Commons, Molecular Biology Commons, Organic
Chemicals Commons, Organic Chemistry Commons, Plants Commons, and the Plant Sciences
Commons
Recommended Citation
Armstrong, Douglas; Krause, Nathan; and Frey, Drew, "Anti-TB and Antibacterial Activities of Natural Products Extracts" (2015).
Faculty Scholarship – Chemistry. 5.
https://digitalcommons.olivet.edu/chem_facp/5

This Article is brought to you for free and open access by the Chemistry at Digital Commons @ Olivet. It has been accepted for inclusion in Faculty
Scholarship – Chemistry by an authorized administrator of Digital Commons @ Olivet. For more information, please contact
digitalcommons@olivet.edu.

Anti-TB and Antibacterial Activities of Natural Products Extracts
Dr. Douglas Armstrong, Nathan Krause, and Drew Frey
Olivet Nazarene University
Bourbonnais, IL 60914
14th International Conference on the Chemistry of Antibiotics and other Bioactive Compounds
October 13-16, 2015
Abstract
Samples of numerous plant species were received from the
southwestern part of the USA from Richard Spjut, and plant
samples were collected here in Illinois. All were extracted with
typical solvents, giving crude residues, some of which were
submitted for anti-TB and/or antibacterial testing. In some cases,
crude extracts were subjected to chromatographic methods.
Some of the fractions were submitted for testing.

Anti-TB Data

Results, Conclusions, and Further Work

Sample

MABA
MIC [ug/ml]

LORA
MIC [ug/ml]

DA-1*

45.8

41.9

DA-19 (fraction 65
of CCC of DA-1)

47.0

DA-17*

>50

DA-3 (fraction 19
of CCC of DA-17)

48.1

DA-12*

22.7

P8

43.1

As for CCC, which we applied only to the sw/usa samples, and
using one of our active crude samples, DA-1, as an example,
although its MIC (minimum inhibitory concentration) values were
appreciably above those of known anti-TB compounds (RMP,
INH, and PA824) used as “standards” for comparisons, we
submitted DA-1 (a crude residue) to CCC, and had selected
fractions tested for anti-TB activity, to see if one or more of the
fractions had about the same or higher activity than the crude
residue. Since at least one of those fractions, DA-19, had about
the same activity, we expect that it contains at least one of the
active compounds. Therefore, we figure that DA-19 is worthy of
further purification.

Introduction
In a general way, bioactive natural products are dealt with very
well by Liang & Fang, 2006 (See “References” section below.)
More specifically, the southwestern part of the United States has a
large variety of indigenous plants many of which have not been
investigated for their medicinal potential, and only very few have
had their extracts separated into the individual compounds they
may contain. But, some information is available for Native
American herbal uses (Moerman, 2003).

Methods
Dry samples of plant materials were ground into powder and
were extracted in a Soxhlex apparatus with hexane or
dichloromethane for 4-8 hours.
The solutions were then
concentrated using a rotavapor, under reduced pressure at about
o
50-60 C, until no more solvent would come off, giving crude
residues which were tested for biological activity. The extracted
solid samples were further extracted using methanol at room
temperature. These solutions were subjected to the same
rotavapor technique (above), producing additional crude residues
which were also tested.
For the residues which are described (above) as crude, no
purification was done on any of them, before the biological
testing. Of course the strategy was to try to figure out which ones
(if any) might be worthy of separation into individual compounds,
which could then be tested.
Thus, counter-current chromatography (CCC) was run on two of
the crude sw/usa residues by Dr. Brent Friesen, and one crude
Illinois residue was subjected to open flash column
chromatography (FCC) on silica gel, run by two of the authors
(DA and DF), under the direction of Jordan Gunn, doctoral
candidate at University of Illinois at Chicago. Selected fractions
(from both methods, CCC and FCC) were submitted for biological
testing.

*Crude extracts.
MIC [uM]
0.04
0.45
0.91

Standards
RMP
INH
PA824

We sent crude residues, selected CCC fractions, and one FCC
fraction (P8) to the Institute for Tuberculosis Research, College of
Pharmacy, University of Illinois at Chicago, where they were
tested for anti-tuberculosis activity, as shown in the “ANTI-TB
DATA” table.

MIC [uM]
0.76
> 128
1.57

We did the same thing with another crude residue, DA-17. One of
its fractions, DA-3, showed higher activity than DA-17. How much
higher we don’t know because (of course) we don’t know how
high “>50” really was (for DA-17) and hence we don’t know how
low its activity really was. DA-3 is also worthy of further
purification. Next, we plan to do the same thing with crude
residue, DA-12.
As for FCC, which we applied only to the plant samples collected
here in Illinois, fraction P8 had anti-TB activity (43.1), but none of
the other FCC fractions had any anti-TB activity. We figure that P8
is worthy of further purification

MABA (Microplate Alamar Blue Assay)
LORA (Low Oxygen Recovery Assay)

Antibacterial Data
MICs in μg/mL
Sample

S.
aureus

P.
aeruginosa

E.
faecium

60-1

64

256

64

62-4

32

128

16

64-3

32

128

16

We also sent crude sw/usa residues to Notre Dame University for
antibacterial testing. Three had activity against one or more of the
bacterial species included in this study, as shown in the
ANTIBACTERIAL DATA table. All samples had values of 256 or
>256 for E. coli, E. aerogenes, A. baumanii, and K. pneumoniae,
so these bacterial species are not included in the table.

References
Moerman , D. (2003). Unpublished raw data, University of
Michigan-Dearborn, Dearborn, Michigan. Retrieved from
http://herb.umd.umich.edu/
Xiao-Tian Liang, Wei-Shuo Fang (editors), Medicinal Chemistry
of Bioactive Natural Products (2006), Wiley-Interscience.

